University of Milan
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
University of Milan
Jun 5, 2024, 06:27 |
Blog
Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024
Giuseppe Curigliano shared on LinkedIn: . "Proud to serve on…
May 26, 2024, 06:54 |
Positive
Yvonne Award Winners 2024 by OncoDaily
We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…
May 24, 2024, 00:14 |
Insight
Margherita Ambrosini: Rare and important subgroup of POLE/D1 proofreading deficient (pd) mCRC treated with ICIs across Europe, USA and Israel
Margherita Ambrosini, Medical Oncology resident at University of Milan, shared on X/Twitter: "Excited and honored to…
May 11, 2024, 13:18 |
Career
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "We're thrilled to announce the…
Aug 18, 2023, 04:56 |
Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
All:
5
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube